We have thoroughly explored the intricate mechanisms underlying the anti-proliferative, anti-migratory and anti-invasive effects of two new in-house hERG activators, SDUY429 and SDUY436, in breast cancer cells. The gene discussed is KCNH2; the disease is breast carcinoma.